e424b3
 

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-132616
Supplement No. 2, dated August 3, 2007
to Prospectus Supplement, dated July 11, 2007,
to Prospectus dated August 21, 2006
 
(LOGO)
 
The following information supplements and amends the prospectus, dated August 21, 2006, as supplemented by the Prospectus Supplement, dated July 11, 2007, of ProLogis relating to the offer and sale from time to time by the selling securitiyholders named therein of ProLogis’ 2.25% Convertible Senior Notes due 2037 and ProLogis’ common shares of beneficial interest which may be issued upon conversion of the notes. This supplement should be read in conjunction with the Prospectus Supplement, dated July 11, 2007, and the Prospectus, dated August 21, 2006.
 
In order to update the information contained in the section entitled “Selling Securityholders”, the following information, which was provided to ProLogis on or prior to July 25, 2007, is added to that section in the Prospectus Supplement, dated July 11, 2007:
 
                                         
    Aggregate
                Other ProLogis
       
    Principal
                Common Shares
       
    Amounts of
          Number of
    Owned Before the
    Percentage of
 
    Notes
          ProLogis
    Offering and
    ProLogis
 
    Beneficially
    Percentage of
    Common Shares
    Assumed to be
    Common
 
    Owned That
    Notes
    That May be
    Owned Following
    Shares
 
Name
  May be Sold     Outstanding(1)     Sold     the Offering     Outstanding(2)  
    (In dollars)                          
 
Medical Liability — Convertible Mutual Insurance Co.(3)
    8,875,000             115,886              
Princeton Medical Mutual Insurance Co.(4)
    1,625,000             21,218              
Kamunting Street Master Fund, Ltd.
    10,000,000             130,576              
Commercial Union Life Fund
    1,2000,000             15,669              
CGNU Life Fund
    1,000,000             13,057              
Norwich Union Life & Pensions
    2,8000,000             36,561                  
Additional Selling Securityholders(5)
    158,164,000       12.6       2,065,242              
 
 
(1) Unless otherwise noted, none of these selling securityholders beneficially owns 1% or more of the outstanding notes.
 
(2) Calculated based on Rule 13d-3 of the Exchange Act using 256,879,781 ProLogis common shares outstanding as of July 1, 2007. In calculating these percentages for each holder of notes, we also treated as outstanding that number of ProLogis common shares issuable upon conversion of that holder’s notes. However, we did not assume the conversion of any other holder’s notes. Based on the foregoing, unless otherwise noted, none of these selling securityholders would beneficially own 1% or more of the outstanding ProLogis common shares following the sale of securities hereunder.
 
(3) Includes $6,800,000 principal amount of notes and 88,791 ProLogis common shares previously listed with respect to Medical Liability — Convertible Mutual Insurance Co. in the Prospectus Supplement, dated July 11, 2007.
 
(4) Includes $1,200,000 principal amount of notes and 15,669 ProLogis common shares previously listed with respect to Princeton Medical Mutual Insurance Co. in the Prospectus Supplement, dated July 11, 2007.
 
(5) As of the date of this Supplement. Additional selling securityholders will be named pursuant to a supplement to the Prospectus Supplement, dated July 11, 2007, with respect to $158,164,000 principal amount of notes and 2,065,242 ProLogis common shares upon our receipt of a questionnaire from the relevant selling securityholder with respect to any such note.